CMAB BioPharm

China
Fucheng, Shanxi, China

Company profile

CMAB BioPharm company profile

CMAB BioPharm is a Biopharmaceutical Service Firm. Suqiao Bio is a flexible, comprehensive biopharmaceutical custom development and production (CDMO) service company. Strictly in compliance with the quality standards of domestic and international pharmaceutical production management regulations, Suqiao Bio is committed to providing Chinese and global customers with a one-stop shop for preclinical and clinical drug Phase I, Phase II, and Phase III biopharmaceutical products from DNA sequences to commercial production. solution.

Business identity

Contact email
[email protected]
Operating status
Closed
Company type
For Profit
Employee range
101-250 employees
Revenue range
$1M-$10M
Founded
2017-01-01, Year

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
2
Total equity funding
$72M
Last funding
Series B / $34M / 2018-04-02
Last equity funding
Series B / $34M
Investors
6
Lead investors
2
Founders
1
Articles
1
Exited on
2021-03-17

Founders and investors

Founders

Qibin Liang

Lead investors

C-Bridge CapitalCD Capital

Investors

C-Bridge CapitalCD CapitalCormorant CapitalQianhai Fund of FundsTigermed